Aliases & Classifications for Berylliosis

About this section

Aliases & Descriptions for Berylliosis:

Name: Berylliosis 10 12 36
 
Beryllium Poisoning 10

Classifications:



External Ids:

Disease Ontology10 DOID:10322
ICD1027 J63.2
SNOMED-CT59 8247009
MeSH36 D001607
UMLS65 C0005138

Summaries for Berylliosis

About this section
Disease Ontology:10 A pneumoconiosis that involves allergic response located in lungs caused by inhalation of beryllium compounds.

MalaCards based summary: Berylliosis, also known as beryllium poisoning, is related to blastomycosis and systemic lupus erythematosus. An important gene associated with Berylliosis is HLA-DPB1 (Major Histocompatibility Complex, Class II, DP Beta 1), and among its related pathways are Glucocorticoid receptor regulatory network and Th2 Differentiation Pathway. Affiliated tissues include lungs, lung and pituitary, and related mouse phenotypes are liver/biliary system and respiratory system.

Wikipedia:68 Berylliosis, or chronic beryllium disease (CBD), is a chronic allergic-type lung response and chronic... more...

Related Diseases for Berylliosis

About this section

Diseases related to Berylliosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 255)
idRelated DiseaseScoreTop Affiliating Genes
1blastomycosis30.6IFNG, POMC, TNF
2systemic lupus erythematosus30.0HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG, IL2, TNF
3chronic beryllium disease12.1
4beryllium disease12.1
5post-infectious myocarditis10.6HLA-DPA1, HLA-DPB1
6lichen planus pemphigoides10.6HLA-DQB1, HLA-DRB1
7tucker syndrome10.6HLA-DQB1, HLA-DRB1
8heavy chain deposition disease10.6HLA-DQB1, HLA-DRB1
9pulmonary coin lesion10.5HLA-DQB1, HLA-DRB1
10congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome10.5HLA-DRB1, TNF
11red cell phospholipid defect with hemolysis10.5HLA-DQB1, HLA-DRB1, IFNG
12mechanical strabismus10.5CD4, IL2
13bipolar ll disorder10.5HLA-DQB1, HLA-DRB1, POMC
14pulmonary nodular lymphoid hyperplasia10.5HLA-DQB1, HLA-DRB1, IFNG
15angioid streaks10.5HLA-DQB1, HLA-DRB1, IL2
16ureterocele10.5IL2, TNF
17acute gonococcal prostatitis10.4CTSA, TNF
18microsomia hemifacial radial defects10.4HLA-DRB1, TNF
19chromophobe renal cell carcinoma10.4ACE, GSTO1
20idiopathic juxtafoveal retinal telangiectasia10.4HLA-DQB1, HLA-DRB1
21human spumaretrovirus infection10.4HLA-DQB1, HLA-DRB1, IL2
22intrahepatic gall duct cancer10.4HLA-DQB1, HLA-DRB1, IFNG
23autoimmune oophoritis10.4IFNG, TNF
24hypochromic microcytic anemia with iron overload10.4ACE, POMC
25autoimmune polyglandular syndrome type 210.4HLA-DQB1, HLA-DRB1, TNF
26neurotic disorder10.4CD4, IFNG, POMC
27pustulosis of palm and sole10.4ACE, TNF
28lymphocytic choriomeningitis10.4HLA-DQB1, HLA-DRB1, TNF
29moderately severe hemophilia a10.4HLA-DQB1, HLA-DRB1, TNF
30hypercementosis10.4HLA-DRB1, IFNG, TNF
31hemorrhagic proctocolitis10.4HLA-DRB1, IFNG, TNF
32hypopharynx cancer10.4HLA-DRB1, POMC, TNF
33cryptosporidiosis10.4HLA-DRB1, IFNG, TNF
34louping ill10.4CD4, IFNG, IL2
35kernicterus due to isoimmunization10.4HLA-DQB1, HLA-DRB1, TNF
36artemis deficiency10.4CD4, HLA-DQB1, IFNG
37cerebral sarcoidosis10.4ACE, TNF
38spinal polio10.4IFNG, IL2
39rectal disease10.4HLA-DQB1, HLA-DRB1, TNF
40skin epithelioid hemangioma10.4IL2, POMC
41argentine hemorrhagic fever10.3IFNG, IL2, TNF
42irf6-related disorders10.3CD4, IFNG, IL2
43ethmoid sinus squamous cell carcinoma10.3CD4, IFNG, TNF
44acute leukemia of ambiguous lineage10.3IFNG, IL2, TNF
45lichtenstein syndrome10.3HLA-DQB1, HLA-DRB1
46tethered spinal cord syndrome10.3IFNG, IL2, TNF
47hodgkin's lymphoma, lymphocytic-histiocytic predominance10.3CD4, IFNG, IL2
48viral meningitis10.3CD4, HLA-DQB1, TNF
49pupil disease10.3HLA-DRB1, IFNG, TNF
50leech infestation10.3IFNG, IL2, TNF

Graphical network of the top 20 diseases related to Berylliosis:



Diseases related to berylliosis

Symptoms for Berylliosis

About this section

Drugs & Therapeutics for Berylliosis

About this section

Drugs for Berylliosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
InfliximabapprovedPhase 1, Phase 2349170277-31-3
Synonyms:
Ig gamma-1 chain C region
 
Inflectra
Remicade
Remsima
2MesalaminePhase 1, Phase 215289-57-6
3Peripheral Nervous System AgentsPhase 1, Phase 218510
4AnalgesicsPhase 1, Phase 29358
5Contraceptives, OralPhase 1, Phase 23734
6Analgesics, Non-NarcoticPhase 1, Phase 25184
7Antirheumatic AgentsPhase 1, Phase 28496
8Anti-Inflammatory AgentsPhase 1, Phase 28478
9Anti-Inflammatory Agents, Non-SteroidalPhase 1, Phase 23549
10Gastrointestinal AgentsPhase 1, Phase 26401
11Dermatologic AgentsPhase 1, Phase 24555
12
Acetylcysteineapproved293616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
13
Heparinapproved, investigational7199005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
14Protective Agents5651
15Respiratory System Agents3931
16Anti-Infective Agents17220
17N-monoacetylcystine293
18Antioxidants2442
19Expectorants337
20Antiviral Agents8071
21calcium heparin719
22Pharmaceutical Solutions7004
23cysteineNutraceutical150

Interventional clinical trials:

idNameStatusNCT IDPhase
1Targeting Oxidative Stress in Chronic Beryllium DiseaseCompletedNCT01088243Phase 1, Phase 2
2Beryllium Infliximab Study: Clinical Interventional TrialTerminatedNCT00111917Phase 1, Phase 2
3Identifying Shared Genetic Susceptibility Regions in Chronic Beryllium Disease and SarcoidosisCompletedNCT00560989
4The Effect of an Oral Antioxidant, N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary SarcoidosisCompletedNCT01587001
5The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)RecruitingNCT02596347
6Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)RecruitingNCT02604693

Search NIH Clinical Center for Berylliosis


Cochrane evidence based reviews: berylliosis

Genetic Tests for Berylliosis

About this section

Anatomical Context for Berylliosis

About this section

MalaCards organs/tissues related to Berylliosis:

33
Lung, Pituitary, Eye, Thyroid, T cells, Skin, Breast

FMA organs/tissues related to Berylliosis:

16
Lungs

Animal Models for Berylliosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Berylliosis:

38 (show all 11)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.8ACE, CTSA, GBA, HLA-DQB1, IFNG, IL2
2MP:00053888.5ALPL, CTSA, CTSK, GBA, HLA-DQB1, IFNG
3MP:00053818.1ALPL, CD4, CTSK, HGS, HLA-DQB1, IFNG
4MP:00053798.1ACE, ALPL, CD4, CTSK, GBA, HLA-DQB1
5MP:00053897.7ACE, ALPL, ALPPL2, CTSA, HGS, HLA-DQB1
6MP:00053977.4ACE, ALPL, CD4, CTSA, CTSK, GBA
7MP:00053767.3ACE, ALPL, CD4, CTSA, CTSK, GBA
8MP:00053847.3ALPL, CD4, CTSA, CTSK, GBA, HGS
9MP:00053857.3ACE, ALPL, CTSA, GBA, HGS, HLA-DQB1
10MP:00053877.1ACE, ALPL, CD4, CTSA, CTSK, GBA
11MP:00053786.3ACE, ALPL, ALPPL2, CD4, CTSA, CTSK

Publications for Berylliosis

About this section

Articles related to Berylliosis:

(show top 50)    (show all 73)
idTitleAuthorsYear
1
Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1I+-TAZ Signaling Pathway in Osteoblasts. (26491017)
2015
2
Valsartan attenuates KIR2.1 by down-regulating the Th1 immune response in rats following myocardial infarction. (26566151)
2015
3
Frontofacial Monobloc Advancement With Simultaneous Frontal Cranioplasty in Adolescents With Residual Apert Syndrome Deformations. (26147044)
2015
4
Theoretical study of enzymatic catalysis explains why the trapped covalent intermediate in the E303C mutant of glycosyltransferase GTB was not detected in the wild-type enzyme. (25138306)
2015
5
Diagnosis and treatment of cerebral venous and sinus thrombosis. (24264471)
2014
6
Early features in neuroimaging of two siblings with molybdenum cofactor deficiency. (24379235)
2014
7
A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors with large cysts containing hemorrhagic fluid in vivo. (23915498)
2013
8
First report of the genetic background of Marfan syndrome in two Polish patients. (24162367)
2013
9
Retinal venous thrombosis in a young patient with coagulation factor xii deficiency. (24269423)
2013
10
Complex visual illusions in a patient with pituitary apoplexy. (23174459)
2013
11
Caries prevalence and socioeconomic factors in children with sickle cell anemia. (22344337)
2012
12
Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy. (22285962)
2012
13
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. (23575054)
2012
14
Treatment of maxillary cleft palate: Distraction osteogenesis vs. orthognathic surgery. (23483803)
2012
15
Localization of PDZD7 to the stereocilia ankle-link associates this scaffolding protein with the Usher syndrome protein network. (23055499)
2012
16
Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. (21858175)
2011
17
Oxidation state of the XRCC1 N-terminal domain regulates DNA polymerase beta binding affinity. (20351257)
2010
18
The stigmata and discrimination experienced, in southern India, by cases of lymphatic filariasis. (20819310)
2010
19
Secondary syphilis resembling erythema multiforme. (20964658)
2010
20
Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. (20422017)
2010
21
HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. (20736364)
2010
22
Heart rate variability in children with congenital sensorineural deafness. (20560254)
2010
23
Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer's disease. (18818379)
2008
24
Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects. (17941898)
2008
25
Physical activity and gallbladder disease determined by ultrasonography. (17986899)
2007
26
Kinase-independent function of cyclin E. (17218276)
2007
27
Clinical evaluation of the efficacy of PEG/PG lubricant eye drops with gelling agent (HP-Guar) for the relief of the signs and symptoms of dry eye disease: a review. (18174974)
2007
28
Safety considerations with niacin therapy. (17368274)
2007
29
Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. (17392798)
2007
30
Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors. (16385588)
2006
31
Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. (16338084)
2006
32
Reconstitution of recycling from the phagosomal compartment in streptolysin O-permeabilized macrophages: role of Rab11. (16563376)
2006
33
Direct electron transfer between copper-containing proteins and electrodes. (15854824)
2005
34
Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5. (15743468)
2005
35
Antiepileptic drug treatment of nonconvulsive seizures induced by experimental focal brain ischemia. (15140918)
2004
36
The human genetics of anorexia nervosa. (14623359)
2003
37
Clinical and immunologic evaluation of 31 patients with acute schistosomiasis mansoni. (11756987)
2002
38
Par-4 is a synaptic protein that regulates neurite outgrowth by altering calcium homeostasis and transcription factor AP-1 activation. (11382383)
2001
39
Transesophageal echocardiographic abnormalities in a case of cardiac sarcoidosis. (11337687)
2001
40
Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms. (10809925)
2000
41
Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. (10566668)
1999
42
Neostigmine for acute colonic pseudo-obstruction. (10577130)
1999
43
The measurement of constitutive and facultative skin pigmentation and estimation of sun exposure in Caucasians with basal cell carcinoma and cutaneous malignant melanoma. (9892904)
1998
44
Expression of CD23, CD32, Mac-1 and other adhesion molecules in eosinophils in strongyloidiasis and HTLV-I-positive patients. (8906113)
1996
45
Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin. (8616907)
1996
46
Controlled proteolysis of Ca(2+)-ATPases in human platelet and non-muscle cell membrane vesicles. Evidence for a multi-sarco/endoplasmic reticulum Ca(2+)-ATPase system. (8119962)
1994
47
Efficacy of cyclosporine in two patients with dermatitis herpetiformis resistant to conventional therapy. (8496445)
1993
48
Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption. (1955511)
1991
49
Group C streptococcal meningitis with favorable recovery. A case report. (2246567)
1990
50
Assessment of hyperacusis in Bell's palsy. (3777730)
1986

Variations for Berylliosis

About this section

Expression for genes affiliated with Berylliosis

About this section
Search GEO for disease gene expression data for Berylliosis.

Pathways for genes affiliated with Berylliosis

About this section

Pathways related to Berylliosis according to GeneCards Suite gene sharing:

(show all 36)
idSuper pathwaysScoreTop Affiliating Genes
19.8IFNG, IL2, POMC
29.7CD4, IFNG, IL2
39.7IFNG, IL2, TNF
4
Show member pathways
9.7IFNG, IL2, TNF
5
Show member pathways
9.7IFNG, IL2, TNF
6
Show member pathways
9.7IFNG, IL2, TNF
79.7CD4, HLA-DRB1, TNF
8
Show member pathways
9.5CD4, HLA-DRB1, IFNG, IL2
99.5CD4, HLA-DRB1, IFNG, IL2
109.4HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
11
Show member pathways
9.4CD4, IFNG, IL2, TNF
129.4CD4, IFNG, IL2, TNF
139.4CD4, IFNG, IL2, TNF
149.4CD4, IFNG, IL2, TNF
159.4CD4, HGS, HLA-DRB1
169.3CD4, HLA-DPA1, HLA-DQB1, HLA-DRB1
179.2CD4, HLA-DRB1, IFNG, IL2, TNF
18
Show member pathways
9.2HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG
199.2HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG
209.2ALPL, ALPP, ALPPL2
21
Show member pathways
9.2ALPL, ALPP, ALPPL2
229.1CD4, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
23
Show member pathways
9.1CD4, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
24
Show member pathways
9.1CD4, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
25
Show member pathways
9.1CD4, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
26
Show member pathways
9.1CD4, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
27
Show member pathways
9.1CD4, HLA-DPA1, HLA-DQB1, HLA-DRB1, IL2
28
Show member pathways
8.9CD4, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL2
298.9HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG, TNF
30
Show member pathways
8.9HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG, TNF
318.9HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL2, TNF
328.9CTSA, CTSK, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
338.8HGS, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
34
Show member pathways
8.6HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG, IL2
358.6CTSK, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG
36
Show member pathways
8.4CD4, HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG

GO Terms for genes affiliated with Berylliosis

About this section

Cellular components related to Berylliosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:004261310.1HLA-DPA1, HLA-DPB1, HLA-DQB1
2integral component of lumenal side of endoplasmic reticulum membraneGO:007155610.0HLA-DPA1, HLA-DPB1, HLA-DQB1
3endosome membraneGO:00100089.6HLA-DPA1, HLA-DPB1, HLA-DQB1
4ER to Golgi transport vesicle membraneGO:00125079.4HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1
5trans-Golgi network membraneGO:00325889.3HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1

Biological processes related to Berylliosis according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1immunoglobulin production involved in immunoglobulin mediated immune responseGO:000238110.7HLA-DQB1, HLA-DRB1
2positive regulation of calcidiol 1-monooxygenase activityGO:006055910.5IFNG, TNF
3positive regulation of membrane protein ectodomain proteolysisGO:005104410.5IFNG, TNF
4positive regulation of chemokine biosynthetic processGO:004508010.5IFNG, TNF
5negative regulation of growth of symbiont in hostGO:004413010.4IFNG, TNF
6positive regulation of isotype switching to IgG isotypesGO:004830410.4IFNG, IL2
7protein import into nucleus, translocationGO:000006010.3IFNG, TNF
8antigen processing and presentation of peptide or polysaccharide antigen via MHC class IIGO:000250410.3HLA-DPA1, HLA-DPB1, HLA-DRB1
9positive regulation of osteoclast differentiationGO:004567210.2IFNG, TNF
10response to glucocorticoidGO:00513849.8ALPL, GBA, TNF
11cytokine-mediated signaling pathwayGO:00192219.7HLA-DPA1, HLA-DPB1, HLA-DRB1, IFNG
12positive regulation of exosomal secretionGO:19035439.6HGS, IFNG
13positive regulation of T cell activationGO:00508709.6CD4, HLA-DPA1, HLA-DPB1
14antigen processing and presentationGO:00198829.6HLA-DPA1, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNG
15immune responseGO:00069559.2CD4, HLA-DRB1, IFNG, IL2, TNF

Sources for Berylliosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet